Opthea Limited (OPT)
USD 3.41
(1.49%)
USD 3.41
(1.49%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -200.01 Million USD | 10.43% |
| 2023 | -134.28 Million USD | -52.45% |
| 2022 | -98.69 Million USD | -145.7% |
| 2021 | -50.36 Million USD | -130.9% |
| 2020 | -16.96 Million USD | 35.68% |
| 2019 | -26.36 Million USD | -13.89% |
| 2018 | -22.38 Million USD | -211.07% |
| 2017 | -7.03 Million USD | -26.99% |
| 2016 | -5.86 Million USD | 13.14% |
| 2015 | -6.74 Million USD | -5.4% |
| 2014 | -6.4 Million USD | 4.12% |
| 2013 | -6.67 Million USD | 26.01% |
| 2012 | -7.73 Million USD | 24.65% |
| 2011 | -11.05 Million USD | -39.69% |
| 2010 | -8.49 Million USD | -41.57% |
| 2009 | -6.86 Million USD | 50.05% |
| 2008 | -12.12 Million USD | 62.24% |
| 2007 | -32.1 Million USD | -1013.05% |
| 2006 | -3.29 Million USD | -121.6% |
| 2005 | 16.56 Million USD | 1163.82% |
| 2004 | -1.78 Million USD | 37.15% |
| 2003 | -1.99 Million USD | -10.0% |
| 2002 | -1.81 Million USD | -337.53% |
| 2001 | -414.98 Thousand USD | -29.4% |
| 2000 | -320.69 Thousand USD | -100.02% |
| 1999 | 1.95 Billion USD | 1642741.29% |
| 1998 | 118.95 Thousand USD | -34.04% |
| 1997 | 180.34 Thousand USD | 123.63% |
| 1996 | -763.11 Thousand USD | -105.11% |
| 1995 | -372.04 Thousand USD | -547.53% |
| 1994 | -57.45 Thousand USD | 75.38% |
| 1993 | -233.39 Thousand USD | -332.3% |
| 1992 | -53.98 Thousand USD | 56.9% |
| 1991 | -125.25 Thousand USD | 74.71% |
| 1990 | -495.24 Thousand USD | -27.34% |
| 1989 | -388.91 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -94.56 Million USD | 0.0% |
| 2024 FY | - USD | -31.28% |
| 2024 Q4 | -98.09 Million USD | 0.0% |
| 2023 FY | - USD | -52.45% |
| 2023 Q4 | -70.76 Million USD | 0.0% |
| 2023 Q2 | -78.8 Million USD | 0.0% |
| 2022 FY | - USD | -145.7% |
| 2022 Q4 | -57.18 Million USD | 0.0% |
| 2022 Q2 | -39.33 Million USD | 0.0% |
| 2021 FY | - USD | -130.9% |
| 2021 Q2 | -19.03 Million USD | 0.0% |
| 2021 Q4 | -20.59 Million USD | 0.0% |
| 2020 FY | - USD | 35.68% |
| 2020 Q4 | -9.04 Million USD | 0.0% |
| 2020 Q2 | -8.11 Million USD | 0.0% |
| 2019 FY | - USD | -13.89% |
| 2019 Q2 | -13.86 Million USD | 0.0% |
| 2019 Q4 | -11.89 Million USD | 0.0% |
| 2018 Q4 | -12.1 Million AUD | 0.0% |
| 2018 Q2 | -10.43 Million USD | 0.0% |
| 2018 FY | - USD | -211.07% |
| 2017 FY | - USD | -26.99% |
| 2017 Q4 | -3.57 Million AUD | 0.0% |
| 2017 Q2 | -3.71 Million USD | 0.0% |
| 2016 Q2 | -1.98 Million USD | 0.0% |
| 2016 FY | - USD | 13.14% |
| 2016 Q4 | -3.71 Million AUD | 0.0% |
| 2015 FY | - USD | -5.4% |
| 2015 Q4 | -3.24 Million AUD | 0.0% |
| 2015 Q2 | -3.72 Million USD | 0.0% |
| 2014 Q2 | -3.27 Million USD | 0.0% |
| 2014 Q4 | -2.95 Million AUD | 0.0% |
| 2014 FY | - USD | 4.12% |
| 2013 Q3 | -1.63 Million USD | 58.99% |
| 2013 FY | - USD | 26.01% |
| 2013 Q2 | -3.99 Million USD | -113.3% |
| 2013 Q1 | -1.87 Million USD | 0.0% |
| 2013 Q4 | -3.2 Million USD | -95.2% |
| 2012 FY | - USD | 24.65% |
| 2012 Q4 | - USD | 100.0% |
| 2012 Q3 | -1.87 Million USD | 1.92% |
| 2012 Q2 | -1.91 Million USD | 28.78% |
| 2012 Q1 | -2.68 Million USD | 0.0% |
| 2011 Q1 | -1.64 Million USD | 0.0% |
| 2011 Q3 | -2.84 Million USD | -3.95% |
| 2011 Q4 | - USD | 100.0% |
| 2011 FY | - USD | -39.69% |
| 2011 Q2 | -2.73 Million USD | -66.14% |
| 2010 Q3 | -1.56 Million USD | -3.18% |
| 2010 Q1 | -2.14 Million USD | 0.0% |
| 2010 FY | - USD | -41.57% |
| 2010 Q4 | - USD | 100.0% |
| 2010 Q2 | -1.51 Million USD | 29.22% |
| 2009 Q1 | 10.17 Thousand USD | 0.0% |
| 2009 Q3 | -1.7 Million USD | -7.22% |
| 2009 FY | - USD | 50.05% |
| 2009 Q4 | - USD | 100.0% |
| 2009 Q2 | -1.59 Million USD | -15753.05% |
| 2008 Q3 | 12.1 Thousand USD | 2.02% |
| 2008 Q1 | 3.73 Million USD | 0.0% |
| 2008 Q2 | 11.86 Thousand USD | -99.68% |
| 2008 Q4 | - USD | -100.0% |
| 2008 FY | - USD | 62.24% |
| 2007 Q1 | -1.12 Million USD | 0.0% |
| 2007 Q4 | - USD | -100.0% |
| 2007 FY | - USD | -1013.05% |
| 2007 Q2 | 3.27 Million USD | 390.24% |
| 2007 Q3 | 3.42 Million USD | 4.45% |
| 2006 FY | - USD | -121.6% |
| 2006 Q3 | -1.07 Million USD | 5.28% |
| 2006 Q2 | -1.13 Million USD | -127.06% |
| 2006 Q4 | - USD | 100.0% |
| 2006 Q1 | 4.18 Million USD | 0.0% |
| 2005 Q2 | 4.26 Million USD | 103.47% |
| 2005 Q3 | 4.24 Million USD | -0.39% |
| 2005 Q4 | - USD | -100.0% |
| 2005 FY | - USD | 1163.82% |
| 2005 Q1 | 2.09 Million USD | 0.0% |
| 2004 Q3 | 2.2 Million USD | -0.93% |
| 2004 Q1 | -1.21 Million USD | 0.0% |
| 2004 Q4 | - USD | -100.0% |
| 2004 Q2 | 2.22 Million USD | 282.55% |
| 2004 FY | - USD | 37.15% |
| 2003 Q1 | -1.55 Million USD | 0.0% |
| 2003 Q2 | -1.04 Million USD | 32.7% |
| 2003 FY | - USD | -10.0% |
| 2003 Q3 | -1.07 Million USD | -2.16% |
| 2003 Q4 | - USD | 100.0% |
| 2002 Q1 | -191.23 Thousand USD | 0.0% |
| 2002 Q2 | -1.45 Million USD | -661.53% |
| 2002 Q4 | - USD | 100.0% |
| 2002 Q3 | -1.52 Million USD | -4.45% |
| 2002 FY | - USD | -337.53% |
| 2001 Q2 | -213.96 Thousand USD | -163.97% |
| 2001 FY | - USD | -29.4% |
| 2001 Q4 | - USD | 100.0% |
| 2001 Q3 | -190.48 Thousand USD | 10.97% |
| 2001 Q1 | 334.45 Thousand USD | 0.0% |
| 2000 FY | - USD | -100.02% |
| 2000 Q1 | 777.15 Thousand USD | 0.0% |
| 2000 Q4 | - USD | -100.0% |
| 2000 Q2 | 396.04 Thousand USD | -49.04% |
| 2000 Q3 | 373.82 Thousand USD | -5.61% |
| 1999 Q3 | 749.04 Thousand USD | 0.27% |
| 1999 Q1 | -294.52 Thousand USD | 3.65% |
| 1999 FY | - USD | 1642741.29% |
| 1999 Q2 | 747.05 Thousand USD | 353.65% |
| 1999 Q4 | - USD | -100.0% |
| 1998 Q4 | -305.67 Thousand USD | 7.87% |
| 1998 Q2 | -336.66 Thousand USD | -32.6% |
| 1998 Q3 | -331.77 Thousand USD | 1.45% |
| 1998 Q1 | -253.89 Thousand USD | 0.0% |
| 1998 FY | - USD | -34.04% |
| 1997 FY | - USD | 123.63% |
| 1997 Q2 | -268.05 Thousand USD | -24.64% |
| 1997 Q1 | -215.06 Thousand USD | -0.2% |
| 1997 Q3 | -274.24 Thousand USD | -2.31% |
| 1997 Q4 | - USD | 100.0% |
| 1996 Q4 | -214.64 Thousand USD | -1.03% |
| 1996 Q1 | -124.9 Thousand USD | -5.73% |
| 1996 FY | - USD | -105.11% |
| 1996 Q2 | -204.15 Thousand USD | -63.45% |
| 1996 Q3 | -212.44 Thousand USD | -4.06% |
| 1995 Q3 | -120.96 Thousand USD | 4.55% |
| 1995 Q2 | -126.73 Thousand USD | -1042.35% |
| 1995 Q1 | -11.09 Thousand USD | -1.58% |
| 1995 FY | - USD | -547.53% |
| 1995 Q4 | -118.13 Thousand USD | 2.34% |
| 1994 Q4 | -10.92 Thousand USD | -3.49% |
| 1994 Q3 | -10.55 Thousand USD | 0.8% |
| 1994 Q2 | -10.63 Thousand USD | 87.1% |
| 1994 Q1 | -82.45 Thousand USD | 3.57% |
| 1994 FY | - USD | 75.38% |
| 1993 Q4 | -85.5 Thousand USD | 4.5% |
| 1993 FY | - USD | -332.3% |
| 1993 Q2 | -86.32 Thousand USD | -518.06% |
| 1993 Q1 | -13.96 Thousand USD | 3.88% |
| 1993 Q3 | -89.53 Thousand USD | -3.72% |
| 1992 FY | - USD | 56.9% |
| 1992 Q1 | -34.66 Thousand USD | -3.93% |
| 1992 Q4 | -14.52 Thousand USD | 2.63% |
| 1992 Q3 | -14.92 Thousand USD | -2.31% |
| 1992 Q2 | -14.58 Thousand USD | 57.93% |
| 1991 Q1 | -127.48 Thousand USD | -4.87% |
| 1991 Q3 | -33.68 Thousand USD | 1.11% |
| 1991 FY | - USD | 74.71% |
| 1991 Q4 | -33.35 Thousand USD | 0.99% |
| 1991 Q2 | -34.06 Thousand USD | 73.28% |
| 1990 Q3 | -115.76 Thousand USD | 2.34% |
| 1990 FY | - USD | -27.34% |
| 1990 Q1 | -103.96 Thousand USD | -2.5% |
| 1990 Q2 | -118.53 Thousand USD | -14.02% |
| 1990 Q4 | -121.55 Thousand USD | -5.0% |
| 1989 Q3 | -109.31 Thousand USD | 6.81% |
| 1989 Q4 | -101.42 Thousand USD | 7.21% |
| 1989 Q2 | -117.3 Thousand USD | 0.0% |
| 1989 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | -4.091% |
| Alkermes plc | 495.04 Million USD | 140.404% |
| Agenus Inc. | -145.92 Million USD | -37.071% |
| Aptorum Group Limited | -9.59 Million USD | -1983.747% |
| Ardelyx, Inc. | -55.35 Million USD | -261.345% |
| Dyadic International, Inc. | -8.22 Million USD | -2330.439% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -68634.973% |
| Lantern Pharma Inc. | -15.78 Million USD | -1167.009% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -904.494% |
| Novavax, Inc. | -487.39 Million USD | 58.961% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -181.621% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -154.824% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -1012.857% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -1906.609% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -248.611% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | 47.359% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -729.544% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 37910.732% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -27.242% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -167.352% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -892.206% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -742.717% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -767.459% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -63.812% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | 22.546% |
| AlloVir, Inc. | -190.14 Million USD | -5.192% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -13.859% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -583.638% |
| Bicycle Therapeutics plc | -183.4 Million USD | -9.061% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -20.915% |
| ChromaDex Corporation | -3.89 Million USD | -5036.589% |
| Chimerix, Inc. | -92.97 Million USD | -115.134% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -350.121% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -77.741% |
| CRISPR Therapeutics AG | -202.7 Million USD | 1.323% |
| Precision BioSciences, Inc. | -32.04 Million USD | -524.239% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -16.135% |
| Fortress Biotech, Inc. | -133.64 Million USD | -49.666% |
| Fortress Biotech, Inc. | -133.64 Million USD | -49.666% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -158.613% |
| ImmuCell Corporation | -2.5 Million USD | -7887.724% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -53.364% |
| Immix Biopharma, Inc. | -16.13 Million USD | -1139.608% |
| Incyte Corporation | 919.42 Million USD | 121.755% |
| Innoviva, Inc. | 248.96 Million USD | 180.342% |
| IO Biotech, Inc. | -91.22 Million USD | -119.252% |
| Jaguar Health, Inc. | -33.13 Million USD | -503.721% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -31.438% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 296.623% |
| ContextLogic Inc. | -324 Million USD | 38.266% |
| MiMedx Group, Inc. | 40.51 Million USD | 593.666% |
| MEI Pharma, Inc. | 26.38 Million USD | 858.221% |
| NextCure, Inc. | -59.03 Million USD | -238.791% |
| Onconetix, Inc. | -36.7 Million USD | -444.91% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 9049.386% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -7169.233% |
| Vaxcyte, Inc. | -464.88 Million USD | 56.975% |
| PDS Biotechnology Corporation | -40.08 Million USD | -398.987% |
| Precigen, Inc. | -89.22 Million USD | -124.171% |
| Pharming Group N.V. | 9.87 Million USD | 2125.096% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -25.759% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -778.74% |
| PureTech Health plc | -11.62 Million USD | -1620.296% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -1077.897% |
| Avidity Biosciences, Inc. | -233.49 Million USD | 14.338% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -729.544% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -128.784% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -590.601% |
| Acelyrin, Inc. | -381.52 Million USD | 47.574% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -1552251.398% |
| Summit Therapeutics Inc. | 1 Million USD | 20081.895% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -499.11% |
| Senti Biosciences, Inc. | -61.33 Million USD | -226.103% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -78.105% |
| Elevation Oncology, Inc. | -41.46 Million USD | -382.357% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -547.226% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -3170.126% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -62211.143% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -516.334% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -2282.31% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -240.226% |
| Seer, Inc. | -97.88 Million USD | -104.341% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -221.589% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -206.003% |
| ESSA Pharma Inc. | -26.45 Million USD | -656.063% |
| GlycoMimetics, Inc. | -39.12 Million USD | -411.269% |
| GT Biopharma, Inc. | 5.97 Million USD | 3445.355% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | 3.229% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -2812.329% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 330.405% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -252.431% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -290.517% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -1923.068% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 62.955% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -2805.56% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -326.825% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | 15.469% |
| Aptose Biosciences Inc. | -52.26 Million USD | -282.679% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -85.644% |
| Soligenix, Inc. | -7.85 Million USD | -2447.085% |
| Century Therapeutics, Inc. | -121.2 Million USD | -65.021% |
| Kura Oncology, Inc. | -164.95 Million USD | -21.257% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -149.718% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -1883.133% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -20784.476% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -4541.884% |
| Autolus Therapeutics plc | -156.77 Million USD | -27.587% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -136.27% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -189.878% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -903.405% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -5.677% |
| GRI Bio, Inc. | -10.89 Million USD | -1735.371% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -4329.393% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -63.273% |
| IGM Biosciences, Inc. | -253.35 Million USD | 21.053% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -92.711% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -424.526% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -1204.677% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -1170.506% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -251.867% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -86.754% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | 24.804% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -3.135% |
| Verastem, Inc. | -83.16 Million USD | -140.505% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -295.513% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -26.412% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -75.318% |
| Histogen Inc. | -10.5 Million USD | -1804.397% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -1300.72% |
| Surrozen, Inc. | -41.13 Million USD | -386.297% |
| Organovo Holdings, Inc. | -14.8 Million USD | -1250.931% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 6237043.249% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -240.671% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -289.946% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -828.635% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -2298.88% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -20.445% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -306.06% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -727.687% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -1228.584% |
| Apollomics, Inc. | -171.74 Million USD | -16.461% |
| Amarin Corporation plc | -50.9 Million USD | -292.952% |
| Mesoblast Limited | -61.33 Million USD | -226.13% |
| Turnstone Biologics Corp. | -56.23 Million USD | -255.69% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -39.677% |
| Synaptogenix, Inc. | -8.3 Million USD | -2307.687% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -1203.988% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -217.253% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -4074.48% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 46720.184% |
| Exelixis, Inc. | 196.6 Million USD | 201.738% |
| Better Therapeutics, Inc. | -38.26 Million USD | -422.761% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -41.447% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 59.609% |
| NLS Pharmaceutics AG | -11.79 Million USD | -1595.699% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 81008.505% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -577.892% |
| Gritstone bio, Inc. | -126.86 Million USD | -57.665% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -207.792% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -4900.537% |
| Avid Bioservices, Inc. | -11.48 Million USD | -1642.172% |
| Insmed Incorporated | -654.73 Million USD | 69.451% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -8790.833% |
| MediWound Ltd. | -4.89 Million USD | -3987.856% |
| OmniAb, Inc. | -49.73 Million USD | -302.201% |
| Alector, Inc. | -142.89 Million USD | -39.979% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -134.121% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -283.56% |
| Zai Lab Limited | -366.57 Million USD | 45.435% |
| Revance Therapeutics, Inc. | -290.63 Million USD | 31.179% |
| Aura Biosciences, Inc. | -83.69 Million USD | -138.982% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | 11.201% |
| Immunic, Inc. | -99.11 Million USD | -101.811% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -51.909% |
| Veracyte, Inc. | -49.4 Million USD | -304.823% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -2731.55% |
| FibroGen, Inc. | -261.4 Million USD | 23.483% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -1695.339% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -2756.869% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -968.655% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 113.8% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -686.794% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 601.426% |
| TG Therapeutics, Inc. | 26.1 Million USD | 866.355% |
| Galecto, Inc. | -37.51 Million USD | -433.113% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -422.72% |
| Fortrea Holdings Inc. | 167.3 Million USD | 219.557% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -48.956% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -606.505% |
| XBiotech Inc. | -35.76 Million USD | -459.243% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -207.792% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -206.542% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -91.488% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -679.132% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -389.438% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 61.271% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -257.042% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -356751.385% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -71.933% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -802.223% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | 14.909% |
| NexImmune, Inc. | -28.16 Million USD | -610.105% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -3519.89% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -1596.185% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 104.298% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -687.724% |
| Scopus BioPharma Inc. | -11.71 Million USD | -1607.643% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -58.939% |
| Ainos, Inc. | -8.77 Million USD | -2179.91% |
| Pluri Inc. | -20.22 Million USD | -888.968% |
| Prothena Corporation plc | -190.1 Million USD | -5.213% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -56.023% |
| Celularity Inc. | -183.94 Million USD | -8.738% |
| Rallybio Corporation | -72.37 Million USD | -176.372% |
| Cue Biopharma, Inc. | -46.05 Million USD | -334.332% |
| MeiraGTx Holdings plc | -57.05 Million USD | -250.59% |
| Omeros Corporation | -163.61 Million USD | -22.253% |
| Humacyte, Inc. | -96.45 Million USD | -107.364% |
| Immunocore Holdings plc | -59.64 Million USD | -235.326% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -932.515% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -720.927% |
| Blueprint Medicines Corporation | -474.61 Million USD | 57.856% |
| CalciMedica, Inc. | -34.18 Million USD | -485.038% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -173.123% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -59.381% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -18.74% |
| Sana Biotechnology, Inc. | -252.39 Million USD | 20.75% |
| Pulmatrix, Inc. | -12.64 Million USD | -1481.676% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -506.743% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -126.094% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 60.495% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -97.618% |
| Cytokinetics, Incorporated | -456.68 Million USD | 56.202% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -499.343% |
| Nutriband Inc. | -5.12 Million USD | -3805.261% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -362.236% |
| Vor Biopharma Inc. | -114.37 Million USD | -74.886% |
| Roivant Sciences Ltd. | -996.51 Million USD | 79.928% |
| Evogene Ltd. | -23.2 Million USD | -762.001% |
| ProKidney Corp. | -147.66 Million USD | -35.451% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -209.938% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -130504.033% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 64.628% |
| CorMedix Inc. | -48.88 Million USD | -309.145% |
| BioLineRx Ltd. | -57.06 Million USD | -250.535% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -78.975% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -98919.193% |
| Atai Life Sciences N.V. | -36.31 Million USD | -450.849% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -151.542% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -145.986% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | 27.399% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -550.679% |
| MediciNova, Inc. | -9.87 Million USD | -1924.488% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -58.819% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -12971.405% |
| GeoVax Labs, Inc. | -26.66 Million USD | -650.011% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | 11.099% |
| Biomea Fusion, Inc. | -124.62 Million USD | -60.503% |
| PTC Therapeutics, Inc. | -330.34 Million USD | 39.451% |
| Mereo BioPharma Group plc | -26.05 Million USD | -667.65% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -5.086% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | 13.013% |
| Absci Corporation | -95.45 Million USD | -109.538% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -566.174% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -86.728% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | 14.33% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -775.164% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | 3.761% |
| Allakos Inc. | -189.91 Million USD | -5.32% |
| Imunon, Inc. | -19.87 Million USD | -906.218% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -84.363% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 284.649% |
| BioAtla, Inc. | -122.24 Million USD | -63.627% |
| NLS Pharmaceutics AG | -11.79 Million USD | -1595.699% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -1169.074% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | 33.392% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -382.589% |
| XOMA Corporation | -39.36 Million USD | -408.152% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -101.522% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -70.012% |
| aTyr Pharma, Inc. | -52.17 Million USD | -283.339% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -138.643% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -34.574% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | 14.728% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -1365.017% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -2387.084% |
| Akari Therapeutics, Plc | -16.8 Million USD | -1090.446% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 106094.918% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 144.257% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -3030.858% |
| UroGen Pharma Ltd. | -63.83 Million USD | -213.357% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -194.513% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -2653.937% |
| Orgenesis Inc. | -60.71 Million USD | -229.423% |
| Entera Bio Ltd. | -8.8 Million USD | -2171.908% |
| GH Research PLC | -41.15 Million USD | -386.037% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -683.803% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -143.234% |
| Xencor, Inc. | -125.87 Million USD | -58.904% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -13921.203% |
| Replimune Group, Inc. | -230.19 Million USD | 13.11% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -892.274% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -1727.991% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -3030.858% |
| Portage Biotech Inc. | -18.19 Million USD | -999.065% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -12971.405% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -91.252% |
| OncoCyte Corporation | -23.12 Million USD | -765.021% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -1670.021% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -1645.846% |
| Purple Biotech Ltd. | -22.22 Million USD | -799.972% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -3020.418% |
| scPharmaceuticals Inc. | -46.06 Million USD | -334.248% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -1023.09% |
| HilleVax, Inc. | -132.46 Million USD | -50.996% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -1781.113% |
| Tharimmune, Inc. | -9.3 Million USD | -2050.141% |
| Genprex, Inc. | -31.06 Million USD | -543.964% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -6.662% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -537.937% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -26080.467% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 132647.03% |
| OKYO Pharma Limited | -15.74 Thousand USD | -1270193.544% |
| Savara Inc. | -59.13 Million USD | -238.252% |
| Curis, Inc. | -45.13 Million USD | -343.117% |
| Daré Bioscience, Inc. | -30.7 Million USD | -551.495% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -1216.68% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -2691.609% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -648.181% |
| BeiGene, Ltd. | -1.12 Billion USD | 82.214% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -1127.019% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 53.547% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -121.407% |
| Erasca, Inc. | -121.31 Million USD | -64.882% |
| bluebird bio, Inc. | -167.16 Million USD | -19.656% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -4346.091% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 164.463% |
| DBV Technologies S.A. | -85.98 Million USD | -132.629% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -4346.091% |
| Moderna, Inc. | -3.28 Billion USD | 93.907% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -369.428% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -3441.409% |
| Molecular Templates, Inc. | 1.43 Million USD | 14087.327% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -234.189% |
| Travere Therapeutics, Inc. | -326.24 Million USD | 38.691% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -45.904% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -322.283% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -43.863% |
| Cogent Biosciences, Inc. | -205.86 Million USD | 2.837% |
| MacroGenics, Inc. | 2.01 Million USD | 10016.647% |
| RenovoRx, Inc. | -11.39 Million USD | -1656.091% |
| Adicet Bio, Inc. | -136.53 Million USD | -46.496% |
| Prime Medicine, Inc. | -193.75 Million USD | -3.231% |
| Aditxt, Inc. | -25.45 Million USD | -685.683% |
| Adagene Inc. | -14.95 Million USD | -1237.848% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -2636.198% |
| Quantum-Si incorporated | -91.8 Million USD | -117.876% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 128.076% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 258.174% |
| SciSparc Ltd. | -5.28 Million USD | -3686.8% |
| Vericel Corporation | 2.86 Million USD | 7083.896% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -209986.096% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -822.11% |
| Generation Bio Co. | -133.3 Million USD | -50.052% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -140.899% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -132.518% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | 12.054% |
| Invivyd, Inc. | -196.61 Million USD | -1.731% |
| Relay Therapeutics, Inc. | -374.15 Million USD | 46.541% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -2056.584% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 836.609% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -1844.762% |
| 2seventy bio, Inc. | -206.41 Million USD | 3.1% |
| ADMA Biologics, Inc. | 5.12 Million USD | 4006.617% |
| Clene Inc. | -43.24 Million USD | -362.567% |
| Capricor Therapeutics, Inc. | -23 Million USD | -769.308% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -312.606% |
| GeoVax Labs, Inc. | -26.66 Million USD | -650.011% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | 33.23% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -444.575% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 948.508% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 4173.49% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -515.783% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -26.271% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 70.771% |
| Evaxion Biotech A/S | -21.4 Million USD | -834.536% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -201.165% |
| Verve Therapeutics, Inc. | -217.66 Million USD | 8.109% |
| Trevena, Inc. | -35.28 Million USD | -466.818% |
| Surrozen, Inc. | -41.13 Million USD | -386.297% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -151.305% |
| Cingulate Inc. | -22.95 Million USD | -771.464% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -2580.857% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -436.488% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -2331.434% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -95.587% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -194.895% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -242.662% |
| Clearmind Medicine Inc. | -8.71 Million USD | -2196.252% |
| Kronos Bio, Inc. | -121.83 Million USD | -64.179% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -169.052% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -8092.743% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -98.378% |
| Statera Biopharma, Inc. | 38.93 Million USD | 613.725% |
| ImmunityBio, Inc. | -436.18 Million USD | 54.143% |
| Korro Bio, Inc. | -80.9 Million USD | -147.23% |
| Kineta, Inc. | -15.71 Million USD | -1172.87% |
| BioVie Inc. | -31.95 Million USD | -526.033% |
| Codexis, Inc. | -49.28 Million USD | -305.858% |
| Celularity Inc. | -183.94 Million USD | -8.738% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | 9.702% |
| Celcuity Inc. | -58.3 Million USD | -243.027% |
| Virax Biolabs Group Limited | -6.6 Million USD | -2926.394% |
| Cibus, Inc. | -314.58 Million USD | 36.418% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -492.947% |
| IN8bio, Inc. | -28.5 Million USD | -601.722% |
| Kodiak Sciences Inc. | -259.02 Million USD | 22.78% |
| Annexon, Inc. | -141.57 Million USD | -41.281% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -77.638% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -211.575% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -615.503% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | 13.039% |
| Eyenovia, Inc. | -24.1 Million USD | -729.746% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 546.63% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -61634.188% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -171.013% |
| Arcellx, Inc. | -64.14 Million USD | -211.823% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -344.348% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -61.99% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -547.687% |
| Moolec Science SA | -52.07 Million USD | -284.094% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -287.588% |
| Geron Corporation | -174.78 Million USD | -14.439% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -394.888% |
| Royalty Pharma plc | 1.88 Billion USD | 110.598% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -67.25% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -2045.145% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -864.376% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -20.435% |
| Humacyte, Inc. | -96.45 Million USD | -107.364% |
| Structure Therapeutics Inc. | -102.45 Million USD | -95.218% |
| 89bio, Inc. | -134.46 Million USD | -48.754% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -153.59% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 5036.297% |
| Genelux Corporation | -24.16 Million USD | -727.721% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -491.772% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -22.363% |
| Notable Labs, Ltd. | -14.4 Million USD | -1289.019% |
| Liquidia Corporation | -70.05 Million USD | -185.533% |
| Mustang Bio, Inc. | -48.06 Million USD | -316.16% |
| Immunovant, Inc. | -269.97 Million USD | 25.913% |
| Quantum-Si incorporated | -91.8 Million USD | -117.876% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -181.772% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -935.937% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -96.074% |
| Acasti Pharma Inc. | -11.3 Million USD | -1669.921% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -798.83% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -1204.677% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | 4.985% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -4583.904% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -1159.564% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -595.089% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -440.153% |
| PepGen Inc. | -83.58 Million USD | -139.308% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -577.938% |
| United Therapeutics Corporation | 1.38 Billion USD | 114.423% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -773.559% |
| Solid Biosciences Inc. | -93.43 Million USD | -114.075% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -4091.74% |
| Immuneering Corporation | -58.06 Million USD | -244.499% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 6237043.249% |
| Silo Pharma, Inc. | -3.62 Million USD | -5415.912% |
| Belite Bio, Inc | -31.52 Million USD | -534.396% |
| XOMA Corporation | -39.36 Million USD | -408.152% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -196.557% |
| Bionomics Limited | -9.83 Million USD | -1933.332% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -138.16% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -477.989% |
| uniQure N.V. | -253.1 Million USD | 20.972% |
| Cassava Sciences, Inc. | -95.68 Million USD | -109.034% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -2636.198% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -54.45% |
| Forte Biosciences, Inc. | -32.47 Million USD | -515.878% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -2384.559% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -608.809% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -61634.188% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -1695.339% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -1157.901% |
| Altimmune, Inc. | -87.93 Million USD | -127.462% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -117.225% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -477.989% |
| Compugen Ltd. | -12.51 Million USD | -1498.105% |
| Peak Bio, Inc. | -1356.23 USD | -14748045.226% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -311.578% |
| Benitec Biopharma Inc. | -22.49 Million USD | -789.368% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | 17.451% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -600.763% |
| Zura Bio Limited | -60.56 Million USD | -230.266% |
| PolyPid Ltd. | -20.26 Million USD | -887.113% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -1181.104% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -600.763% |
| Instil Bio, Inc. | -146.12 Million USD | -36.885% |
| argenx SE | -216.02 Million USD | 7.409% |
| Immunome, Inc. | -28.27 Million USD | -607.505% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -312.64% |
| Verona Pharma plc | -52.46 Million USD | -281.224% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -111.053% |
| Shattuck Labs, Inc. | -87.61 Million USD | -128.293% |
| CervoMed Inc. | -2.17 Million USD | -9109.502% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -63.623% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -1475.82% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -315.201% |
| Moolec Science SA | -52.07 Million USD | -284.094% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -1066.972% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -53.399% |
| AnaptysBio, Inc. | -143.16 Million USD | -39.713% |
| Design Therapeutics, Inc. | -66.32 Million USD | -201.574% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -146.976% |
| NeurAxis, Inc. | -6.66 Million USD | -2901.259% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -429.851% |
| Lumos Pharma, Inc. | -36.57 Million USD | -446.948% |
| Achilles Therapeutics plc | -70.44 Million USD | -183.948% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -111.053% |
| 180 Life Sciences Corp. | -22.13 Million USD | -803.671% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 3531.297% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -8092.743% |
| Nutriband Inc. | -5.12 Million USD | -3805.261% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -82.253% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -260.836% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -295.685% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -206.415% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -269.653% |
| Palisade Bio, Inc. | -12.28 Million USD | -1528.685% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -340.803% |
| Beam Therapeutics Inc. | -156.47 Million USD | -27.83% |
| Neurogene Inc. | -52.28 Million USD | -282.547% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -46.545% |
| AEON Biopharma, Inc. | -48.36 Million USD | -313.595% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -115.032% |
| Sesen Bio, Inc. | -50.84 Million USD | -293.428% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -144.128% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -1519.582% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 53.205% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -90.137% |
| Athira Pharma, Inc. | -116.7 Million USD | -71.391% |
| Vaccinex, Inc. | -19.74 Million USD | -912.856% |
| HCW Biologics Inc. | -23.57 Million USD | -748.398% |
| XOMA Corporation | -39.36 Million USD | -408.152% |
| Nektar Therapeutics | -243.1 Million USD | 17.724% |
| Arvinas, Inc. | -394.8 Million USD | 49.337% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 106094.918% |
| Merus N.V. | -149.2 Million USD | -34.055% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -113.947% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -539.855% |
| Rezolute, Inc. | -68.42 Million USD | -192.327% |
| Clene Inc. | -43.24 Million USD | -362.567% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -1196.954% |
| BeyondSpring Inc. | -21.54 Million USD | -828.592% |
| Synlogic, Inc. | -55.16 Million USD | -262.609% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -1555.373% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -1779.522% |
| Peak Bio, Inc. | -1356.23 USD | -14748045.226% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -516.106% |
| Krystal Biotech, Inc. | 17.9 Million USD | 1217.174% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -68.902% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | 41.403% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -4242.163% |
| MannKind Corporation | 15.12 Million USD | 1422.089% |
| Ikena Oncology, Inc. | -74.39 Million USD | -168.853% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -1488.333% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 1084.005% |
| Gossamer Bio, Inc. | -172.15 Million USD | -16.187% |
| CohBar, Inc. | -12.06 Million USD | -1557.739% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -684.111% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -566.174% |
| Legend Biotech Corporation | -477.87 Million USD | 58.144% |
| Mural Oncology plc | -192.72 Million USD | -3.787% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -75.372% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -1138.869% |
| Disc Medicine, Inc. | -91.02 Million USD | -119.74% |
| Champions Oncology, Inc. | -5.05 Million USD | -3857.633% |
| REGENXBIO Inc. | -239.46 Million USD | 16.472% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -1766.162% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -258.739% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -415.934% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -77.312% |
| Vaxart, Inc. | -74.72 Million USD | -167.68% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -468.101% |
| Cellectis S.A. | -98.09 Million USD | -103.903% |
| Longeveron Inc. | -20.06 Million USD | -897.103% |
| Repare Therapeutics Inc. | -114.27 Million USD | -75.036% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 54.458% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -167.362% |
| Revolution Medicines, Inc. | -430.58 Million USD | 53.547% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -3080.454% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -549.644% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -168.158% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 4179.518% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -1724.157% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 104.343% |
| Denali Therapeutics Inc. | -179.97 Million USD | -11.138% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -209986.096% |
| Veru Inc. | -89.97 Million USD | -122.303% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -644.173% |
| Cingulate Inc. | -22.95 Million USD | -771.464% |
| Passage Bio, Inc. | -98.34 Million USD | -103.393% |
| Context Therapeutics Inc. | -25.06 Million USD | -698.141% |
| Exicure, Inc. | -15.53 Million USD | -1187.205% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | 2.934% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -440.942% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -3254.558% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -18.731% |
| Nuvalent, Inc. | -149.49 Million USD | -33.799% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -2359.525% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -132.867% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -562.797% |
| OmniAb, Inc. | -49.73 Million USD | -302.201% |
| Anew Medical, Inc. | -1.3 Million USD | -15276.124% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -1517.751% |
| Lipocine Inc. | -16.32 Million USD | -1125.405% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -200.013% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -169.193% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -424.526% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -412.685% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -801.676% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 63.304% |
| Ocugen, Inc. | -64.82 Million USD | -208.542% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -116.073% |
| Q32 Bio Inc. | -86.5 Million USD | -131.23% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -1081.655% |
| Alumis Inc. Common Stock | -156.89 Million USD | -27.49% |
| Equillium, Inc. | -12.13 Million USD | -1547.873% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -242.076% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -2430.81% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -960.49% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -328.379% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -88.085% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -1018.261% |
| Dominari Holdings Inc. | -22.44 Million USD | -791.349% |
| Edesa Biotech, Inc. | -8.19 Million USD | -2342.189% |
| vTv Therapeutics Inc. | -25.41 Million USD | -687.104% |
| Bio-Techne Corporation | 326.66 Million USD | 161.231% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | 48.029% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 192.435% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -52.56% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -434.367% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -32.374% |
| Nkarta, Inc. | -120.48 Million USD | -66.017% |
| BioCardia, Inc. | -11.56 Million USD | -1630.266% |
| Iterum Therapeutics plc | -34.58 Million USD | -478.423% |